Companies: 10,795·Total market cap: $144.5T
Emerald Health Therapeutics, Inc.

Emerald Health Therapeutics, Inc.

EMHTFOTCHealthcare
$0.04
+$0.01(+55.17%)
Market Cap$0
P/E Ratio
52W High$0.0681
52W Low$0.02
Overview
Foreign Private Issuer · Files 20-F / 6-K

Emerald Health Therapeutics, Inc. (EMHTF) SEC Filings & 10-K Annual Reports

SEC EDGAR regulatory submissions (10-K, 10-Q, 8-K), latest forms, and full filing history — quick links to financials and earnings below.

SEC EDGAR · data.sec.gov · CIK 0001768225 · EMHTF · OTC · as of Jun 9, 2026

Filing snapshot

78
Total Filings
15-15D
Latest Form
2021-04-01
Most Recent
2015
Filing Since

Source: SEC EDGAR (data.sec.gov) · CIK 0001768225 · Updated hourly · Not investment advice

Latest Annual Report

20-F · Annual Report (Foreign Issuer)FY
Filed Date
2020-06-10
Fiscal Year End
Jun 10, 2020
Accession No.
0001176256-20-000211
Primary Document
emeraldhealth20f.htm
Source: data.sec.gov · CIK 0001768225 · Accession 0001176256-20-000211

Latest Key Filings

6-KQuarterly Report
FORM 6-K
2021-03-17
8-KCurrent Report

No recent filings

Form 4Insider Activity
Ownership Change Disclosures

Executive & director trade disclosures. Full buy/sell sentiment analysis on the dedicated tab.

SEC Filing History

Hide Form 4 / 144
15-15D15-15D
15-15D
2021-04-01
View
RWRW
REQUEST FOR WITHDRAWAL
2021-03-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2021-03-17
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2021-03-10
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2021-02-18
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2021-02-09
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2021-02-05
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2021-01-13
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2020-12-29
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2020-12-17
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2020-12-04
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2020-12-02
View
6-KCurrent Report (Foreign Issuer)
REPORT OF FOREIGN PRIVATE ISSUER FOR THE MONTH OF NOVEMBER, 2020
2020-11-30
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2020-11-24
View
6-KCurrent Report (Foreign Issuer)
FORM 6-K
2020-11-02
View
Showing 1–15 of 78 filingsForm 4 / 144 hidden

About SEC Filings & 10-K Annual Reports

Data source: SEC EDGAR (data.sec.gov)  |  Updated: Hourly  |  CIK: 0001768225  |  Exchange: OTC · Healthcare

Emerald Health Therapeutics, Inc. (OTC: EMHTF) has submitted 78 documents to the U.S. Securities and Exchange Commission (SEC) since its IPO in 2015. As a Healthcare sector company with CIK 0001768225, all filings are publicly accessible via the EDGAR database at no cost.

The annual 10-K report is Emerald Health Therapeutics, Inc.'s most comprehensive regulatory disclosure. The most recent Emerald Health Therapeutics, Inc. 10-K was filed on 2020-06-10 for fiscal year ending 2020. Historical EMHTF 10-K annual reports are available from 2019 through 2020.

Investors researching Emerald Health Therapeutics, Inc. SEC filings can access 10-K annual reports, quarterly 10-Q reports, material event 8-K filings, and proxy statements directly from the links above. All documents are sourced from the official SEC EDGAR system.

Source: SEC EDGAR · data.sec.gov · SEC Form 10-K · SEC Form 10-Q · SEC Form 8-K2026-06-09

Frequently Asked Questions

EMHTF SEC Filings · 8 questions

Emerald Health Therapeutics, Inc. (EMHTF) SEC filings are publicly available on this page and on the official SEC EDGAR database at sec.gov. You can browse all 78 filings and access original documents at no cost. Emerald Health Therapeutics, Inc.'s CIK is 0001768225.

EMHTF SEC filingsEmerald Health Therapeutics, Inc. SEC documentsfind EMHTF 10-K